Product Description
Cartalax | 20mg
Researching Cartilage and Connective-Tissue Health
What It Does
Cartalax is a short bioregulator peptide from the Khavinson cytogen family, studied in the context of cartilage and connective-tissue health. Its sequence mirrors a fragment found in cartilage collagen, so it is investigated as a signalling molecule, a message to the cells that maintain your joints. It acts on chondrocytes and fibroblasts, and studies suggest it can raise cell-proliferation markers while dampening the matrix-breakdown and cell-death pathways tied to connective-tissue aging.
What Researchers Study It For
- Cartilage tissue maintenance
- Connective-tissue regulation
- Chondrocyte proliferation support
- Extracellular matrix remodelling
- Musculoskeletal cellular aging
Technical Background
Cartalax is a short-peptide bioregulator (cytogen) whose sequence corresponds to a cartilage/collagen-associated fragment; its proposed mechanism is gene-regulatory. Supplied strictly for laboratory research use only.
99%+ HPLC-verified purity. For research use only.